메뉴 건너뛰기




Volumn 123, Issue 10, 2014, Pages 1470-1478

Childhood high-risk acute lymphoblastic leukemia in first remission: Results after chemotherapy or transplant from the AIEOP ALL 2000 study

(25)  Conter, Valentino a   Valsecchi, Maria Grazia a   Parasole, Rosanna b   Putti, Maria Caterina c   Locatelli, Franco d,e   Barisone, Elena f   Nigro, Luca Lo g   Santoro, Nicola h   Aricò, Maurizio i   Ziino, Ottavio j   Pession, Andrea k   Testi, Anna Maria l   Micalizzi, Concetta m   Casale, Fiorina n   Zecca, Marco o   Casazza, Gabriella p   Tamaro, Paolo q   La Barba, Gaetano r   Notarangelo, Lucia Dora s   Silvestri, Daniela a   more..


Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; IFOSFAMIDE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; TIOGUANINE; VINCRISTINE; VINDESINE;

EID: 84897506451     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-10-532598     Document Type: Article
Times cited : (76)

References (25)
  • 2
    • 77951441599 scopus 로고    scopus 로고
    • Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: Results in 3184 patients of the AIEOPBFM ALL 2000 study
    • Conter V, Bartram CR, Valsecchi MG, et al. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOPBFM ALL 2000 study. Blood. 2010;115(16):3206-3214.
    • (2010) Blood , vol.115 , Issue.16 , pp. 3206-3214
    • Conter, V.1    Bartram, C.R.2    Valsecchi, M.G.3
  • 7
    • 38349143355 scopus 로고    scopus 로고
    • Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: Insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy
    • Aricò M, Valsecchi MG, Rizzari C, et al. Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy. J Clin Oncol. 2008;26(2):283-289.
    • (2008) J Clin Oncol , vol.26 , Issue.2 , pp. 283-289
    • Aricò, M.1    Valsecchi, M.G.2    Rizzari, C.3
  • 8
    • 47149100125 scopus 로고    scopus 로고
    • Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: Treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95
    • German-Austrian-Swiss ALL-BFM Study Group
    • Möricke A, Reiter A, Zimmermann M, et al German-Austrian-Swiss ALL-BFM Study Group. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood. 2008;111(9):4477-4489.
    • (2008) Blood , vol.111 , Issue.9 , pp. 4477-4489
    • Möricke, A.1    Reiter, A.2    Zimmermann, M.3
  • 9
    • 0034667685 scopus 로고    scopus 로고
    • Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia
    • Coustan-Smith E, Sancho J, Hancock ML, et al. Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia. Blood. 2000;96(8):2691-2696.
    • (2000) Blood , vol.96 , Issue.8 , pp. 2691-2696
    • Coustan-Smith, E.1    Sancho, J.2    Hancock, M.L.3
  • 10
    • 0032572924 scopus 로고    scopus 로고
    • Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia
    • European Organization for Research and Treatment of Cancer-Childhood Leukemia Cooperative Group. European Organization for Research and Treatment of Cancer - Childhood Leukemia Cooperative Group
    • Cavé H, van der Werff ten Bosch J, Suciu S, et al; European Organization for Research and Treatment of Cancer-Childhood Leukemia Cooperative Group. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer - Childhood Leukemia Cooperative Group. N Engl J Med. 1998;339(9):591-598.
    • (1998) N Engl J Med , vol.339 , Issue.9 , pp. 591-598
    • Cavé, H.1    Van Der Werff Ten Bosch, J.2    Suciu, S.3
  • 11
    • 35148838428 scopus 로고    scopus 로고
    • Analyzing survival curves at a fixed point in time
    • DOI 10.1002/sim.2864
    • Klein JP, Logan B, Harhoff M, Andersen PK. Analyzing survival curves at a fixed point in time. Stat Med. 2007;26(24):4505-4519. (Pubitemid 47534694)
    • (2007) Statistics in Medicine , vol.26 , Issue.24 , pp. 4505-4519
    • Klein, J.P.1    Logan, B.2    Harhoff, M.3    Andersen, P.K.4
  • 14
    • 76749171200 scopus 로고    scopus 로고
    • Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia
    • Associazione Italiana di Ematologia ed Oncologia Pediatrica
    • Conter V, Aricò M, Basso G, et al; Associazione Italiana di Ematologia ed Oncologia Pediatrica. Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia. Leukemia. 2010;24(2):255-264.
    • (2010) Leukemia , vol.24 , Issue.2 , pp. 255-264
    • Conter, V.1    Aricò, M.2    Basso, G.3
  • 15
    • 76749102418 scopus 로고    scopus 로고
    • Longterm results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000
    • Möricke A, Zimmermann M, Reiter A, et al. Longterm results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia. 2010;24(2):265-284.
    • (2010) Leukemia , vol.24 , Issue.2 , pp. 265-284
    • Möricke, A.1    Zimmermann, M.2    Reiter, A.3
  • 16
    • 84866652995 scopus 로고    scopus 로고
    • Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemia
    • Conklin HM, Krull KR, Reddick WE, Pei D, Cheng C, Pui CH. Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemia. J Natl Cancer Inst. 2012;104(18):1386- 1395.
    • (2012) J Natl Cancer Inst , vol.104 , Issue.18 , pp. 1386-1395
    • Conklin, H.M.1    Krull, K.R.2    Reddick, W.E.3    Pei, D.4    Cheng, C.5    Pui, C.H.6
  • 19
    • 84865541969 scopus 로고    scopus 로고
    • Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: Results from the CCG-1961 randomised cohort trial
    • Children's Oncology Group
    • Mattano LA Jr, Devidas M, Nachman JB, et al Children's Oncology Group. Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial. Lancet Oncol. 2012;13(9):906-915.
    • (2012) Lancet Oncol , vol.13 , Issue.9 , pp. 906-915
    • Mattano Jr., L.A.1    Devidas, M.2    Nachman, J.B.3
  • 20
    • 84859534539 scopus 로고    scopus 로고
    • Outcomes after induction failure in childhood acute lymphoblastic leukemia
    • Schrappe M, Hunger SP, Pui CH, et al. Outcomes after induction failure in childhood acute lymphoblastic leukemia. N Engl J Med. 2012;366(15):1371-1381.
    • (2012) N Engl J Med , vol.366 , Issue.15 , pp. 1371-1381
    • Schrappe, M.1    Hunger, S.P.2    Pui, C.H.3
  • 21
    • 84865168175 scopus 로고    scopus 로고
    • Pediatric acute lymphoblastic leukemia: Where are we going and how do we get there?
    • Pui CH, Mullighan CG, Evans WE, Relling MV. Pediatric acute lymphoblastic leukemia: where are we going and how do we get there? Blood. 2012;120(6):1165-1174.
    • (2012) Blood , vol.120 , Issue.6 , pp. 1165-1174
    • Pui, C.H.1    Mullighan, C.G.2    Evans, W.E.3    Relling, M.V.4
  • 25
    • 84880308800 scopus 로고    scopus 로고
    • High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation
    • Marshall GM, Dalla Pozza L, Sutton R, et al. High-risk childhood acute lymphoblastic leukemia in first remission treated with novel intensive chemotherapy and allogeneic transplantation. Leukemia. 2013;27(7):1497-1503.
    • (2013) Leukemia , vol.27 , Issue.7 , pp. 1497-1503
    • Marshall, G.M.1    Dalla Pozza, L.2    Sutton, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.